Evidence map›Paper›PMID 32131561›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Structural Modification of Nanomicelles through Phosphatidylcholine: The Enhanced Drug-Loading Capacity and Anticancer Activity of Celecoxib-Casein Nanoparticles for the Intravenous Delivery of Celecoxib.

Liuli Xv, Xinxin Qian, Yan Wang, Chenghuan Yu, Dingkui Qin, Yahui Zhang, Peng Jin, Qizhen Du

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Recent Advances in Nanomicelles Delivery Systems.Nanomaterials (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liuli XvThe Key Laboratory for Quality Improvement of Agricultural Products of Zhejiang Province, College of Agricultural and Food Sciences, Zhejiang A & F University, Hangzhou 311300, China.
Xinxin QianThe Key Laboratory for Quality Improvement of Agricultural Products of Zhejiang Province, College of Agricultural and Food Sciences, Zhejiang A & F University, Hangzhou 311300, China.
Yan WangThe Key Laboratory for Quality Improvement of Agricultural Products of Zhejiang Province, College of Agricultural and Food Sciences, Zhejiang A & F University, Hangzhou 311300, China.
Chenghuan YuExperimental Animal Center of the Zhejiang Academy of Medical Sciences, Hangzhou 310013, China.
Dingkui QinThe Key Laboratory for Quality Improvement of Agricultural Products of Zhejiang Province, College of Agricultural and Food Sciences, Zhejiang A & F University, Hangzhou 311300, China.
Yahui ZhangThe Key Laboratory for Quality Improvement of Agricultural Products of Zhejiang Province, College of Agricultural and Food Sciences, Zhejiang A & F University, Hangzhou 311300, China.
Peng JinThe Key Laboratory for Quality Improvement of Agricultural Products of Zhejiang Province, College of Agricultural and Food Sciences, Zhejiang A & F University, Hangzhou 311300, China.ORCID 0000-0003-0032-8914
Qizhen DuThe Key Laboratory for Quality Improvement of Agricultural Products of Zhejiang Province, College of Agricultural and Food Sciences, Zhejiang A & F University, Hangzhou 311300, China.ORCID 0000-0003-2969-2840

Funding

the Key R&D Program Project of Zhejiang Province, China 2019C02072the Natural Science Foundation of Zhejiang Province, China Q19C200024
6 · The paper itself

Abstract

This study aims to stabilize loaded celecoxib (CX) by modifying the structure of casein nanoparticles through phosphatidylcholine. The results show that Egg yolk phosphatidylcholine PC

Indexed as

anticancercasein nanoparticlescelecoxibdeliverystability

Identifiers

PMID32131561
PMCPMC7153595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.